Gilead Sciences
Leadership Diversity:
35%
65%
People of Color
White
Gilead Sciences
Leadership Diversity:
41%
59%
Female
Male

Gilead Sciences

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

Description from Wikipedia

Take Action

Leadership Team